Idorsia Pharmaceutical sees highest filings and grants during September in Q3 2023

Idorsia Pharmaceutical has been focused on protecting inventions in Taiwan(TW) with 6 publications in Q3 2023

The Taiwan(TW) Patent Office dominates the patent filings and grants with nearly 16% filings and 25% grants. The Taiwan(TW), United States(US), Australia(AU), and European Patent Office(EPO) patent Office are among the top ten patent offices where Idorsia Pharmaceutical is filings its patents. Among the top granted patent authorities, Idorsia Pharmaceutical has 25% of its grants in Taiwan(TW), 25% in United States(US), and 25% in Canada(CA).

Johnson & Johnson could be the strongest competitor for Idorsia Pharmaceutical

Johnson & Johnson and Pfizer secured the top positions according to recent patent publication data.

Patents related to rare diseases and climate change lead Idorsia Pharmaceutical’s portfolio

Idorsia Pharmaceutical has the highest number of patents in rare diseases followed by, climate change and addiction. For rare diseases, nearly 100% of patents were filed and 71% of patents were granted in Q3 2023.

Petrochemicals related patents lead Idorsia Pharmaceutical portfolio followed by neurodegenerative diseases, and fibrosis

Idorsia Pharmaceutical has highest number of patents in petrochemicals followed by neurodegenerative diseases, fibrosis, myocardial infarction and polycystic kidney disease. For petrochemicals, nearly 6% of patents were filed and 4% of patents were granted in Q3 2023.

For comprehensive analysis of Idorsia Pharmaceutical‘s filings and grants, buy the databook here.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.